• SMAD3 Inhibition, miRNA-140, and Early OA

  2026-08-31

  Xiang et al. investigated how SMAD3 inhibition affects the cartilage-degrading enzyme ADAMTS-5 during early osteoarthritis. Their in vitro and rat studies support a regulatory link between SMAD3, miRNA-140, and ADAMTS-5, identifying a molecular window in which pathway inhibition changes catabolic signaling before major cartilage-structure abnormalities become evident.

• P2RX1-Driven Mitochondrial Apoptosis in Ph+ ALL

  2026-08-30

  Li et al. identify P2RX1 as a regulator of tyrosine kinase inhibitor sensitivity in Philadelphia chromosome-positive acute lymphoblastic leukemia, linking calcium/CaMKII activity to mitochondrial dysfunction and PI3K/Akt suppression. The findings provide a mechanistic framework for studying treatment-induced cell death while highlighting the need for validation in patient-derived and in vivo models.

• Bafilomycin A1 in Lysosomal Stress Assays

  2026-08-29

  Bafilomycin A1 is a reversible V-ATPase inhibitor that helps separate lysosomal acidification from metabolic-stress signaling. This guide translates recent AMPK-SQSTM1 research into practical assay design, controls, and interpretation strategies.

• Engineering Precision in CRISPR-Cas9 mRNA

  2026-08-28

  A mechanistic and translational analysis of how Cap1 capping, m1Ψ modification, poly(A) design, and Cas9 mRNA trafficking can shape CRISPR-Cas9 genome editing performance and specificity.

• CCR7–Notch1 Crosstalk Drives Mammary Cancer Stemness

  2026-08-28

  Boyle et al. show that CCR7 and Notch1 form a functional signaling circuit that maintains stem-like properties in MMTV-PyMT mammary cancer cells. The study supports a mechanistic rationale for dual pathway investigation, while its mouse-model and ex vivo design requires careful validation before clinical translation.

• Aurora Kinase A in High-Risk Retinoblastoma

  2026-08-27

  A 2024 study found that Aurora kinase A is overexpressed in human retinoblastoma and associated with histopathologic features linked to poor clinical risk. By combining patient-tissue analysis with genetic depletion, pharmacologic inhibition, patient-derived models, xenografts, and enucleated specimens, the investigators provide a strong preclinical rationale for evaluating Aurora A as a therapeutic target in advanced or chemotherapy-refractory disease.

• HRP Goat Anti-Mouse IgG (H+L) Antibody Guide

  2026-08-27

  HRP Goat Anti-Mouse IgG (H+L) Antibody, SKU K1221, provides an HRP-linked detection layer for mouse IgG primary antibodies in Western blotting, ELISA, IHC, and ICC. It should not be selected for non-mouse primary antibodies, direct primary-antibody detection, or workflows that require a fluorescent or otherwise non-HRP reporter.

• Danazol as a Causal Probe of Pubertal Timing

  2026-08-26

  Danazol is more than an androgenic steroid tool: it can function as a mechanistic perturbation for studying hypothalamic–pituitary–gonadal axis timing. This article interprets recent rat-model evidence and translates it into stronger assay design, controls, and translational decisions.

• Risedronate Sodium: Applied Research Workflows

  2026-08-26

  Risedronate Sodium combines osteoclast-directed pharmacology with emerging lung-targeted delivery strategies, making it useful for bone metabolism research, formulation development, and exploratory pulmonary assays. This practical guide covers assay design, dosing logic, dendrimer-based delivery, and troubleshooting from cell culture through animal studies.

• KPT330 and Precision CRISPR-Cas9 Editing

  2026-08-25

  The reference study identifies selective inhibitors of nuclear export, particularly KPT330, as indirect regulators of Cas9, base-editor, and prime-editor activity. By limiting nuclear export of Cas9 mRNA rather than binding the Cas9 protein directly, this approach reduces excessive editing activity and improves precision in human-cell models.

• Rapid Microwave Heating Preserves Lactoferrin

  2026-08-25

  A recent Food Research International study shows that heating rate, rather than a unique microwave dielectric effect, is the main determinant of lactoferrin preservation during processing. By comparing microwave, conventional, and microwave-simulated thermal treatments, the authors connect rapid passage through the denaturation range with reduced structural damage, aggregation, and loss of biological activity.

• Erastin B1524: Reliable Ferroptosis Assays

  2026-08-24

  This scenario-based guide explains how Erastin SKU B1524 can improve ferroptosis assay design, compound handling, and interpretation in RAS/BRAF-relevant tumor models. It connects product-backed preparation parameters with orthogonal oxidative-stress and membrane-injury readouts for more defensible cancer biology research.

• Nystatin (Fungicidin) for Candida Research

  2026-08-24

  Nystatin (Fungicidin) gives researchers a mechanistically direct way to probe ergosterol-dependent membrane damage, Candida adhesion, biofilms, and polyene combinations. This workflow-focused guide connects concentration planning and formulation control with the recent finding that moxidectin can potentiate Nystatin activity against Candida albicans.

• From MRF to Mechanism: Dual-Luciferase Translation

  2026-08-23

  The 2025 MRF–FSHR study provides a compelling mechanistic starting point for investigating osteogenic differentiation in BMSCs. This article explains how a Dual Luciferase Reporter Gene System can convert that biology into a focused, normalized promoter-activity strategy while clarifying assay limitations, translational value, and opportunities beyond conventional product-page guidance.

• O-GlcNAcylation Rewires Wnt-Driven Bone Formation

  2026-08-22

  The reference study identifies O-GlcNAcylation as a metabolic and post-translational mechanism that enables Wnt-stimulated osteogenesis. Its central finding is that Wnt3a modifies PDK1 at Ser174, stabilizing PDK1 and increasing aerobic glycolysis, thereby linking glucose metabolism to bone formation and fracture repair.

7985 records 1/533 page Next 12345 下5页 Last page